← Back to all trials
Not Yet Recruiting
NCT07789678
Epidemiological Profile of Patients With IDH-Mutant Diffuse Gliomas Diagnosed From 2021 in Brazil
Conditions: Diffuse Glioma, IDH-mutant Gliomas
Sex: All
Ages: 12 Years – N/A
Healthy volunteers: No
Enrollment: 350
Sponsor: Latin American Cooperative Oncology Group
Location: IESG Instituto de Ensino da Saúde e Gestão Salvador Estado de Bahia
Summary
This is a real-world, retrospective, non-interventional, single-arm, multi-center Brazilian study that will include patients diagnosed with IDH-mutant diffuse glioma in Brazil from 2021. Eligible patients will be included in this study to have their medical charts data collected by site personnel. Included patients won´t be requested to attend protocol-specific visits and treatment decisions and disease management will be at the investigator's discretion
Eligibility Criteria
Inclusion Criteria:
* Male or female patients (aged 12 years or older);
* Histologically confirmed diagnosis of diffuse glioma from 2021;
* Confirmed IDH mutation identified by IHC or PCR/NGS;
* Willing and able to provide written informed consent, applicable to living patients. In case of patients \
Source: ClinicalTrials.gov (NCT07789678). StuddyBuddy aggregates publicly available trial information.
